SCHEMBL18895974

SCHEMBL18895974

CNCC/C=C1\COc2ccc(C(C)(C)O)cc2\C1=C\CN1CCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.38
▸ HRH1 P35367 5/20 0.34
▸ TBXA2R P21731 2/20 0.34
▸ LMNA P02545 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ SLC6A2 P23975 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ ADRB2 P07550 1/20 0.33
▸ RET P07949 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ CYP2C8 P10632 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15478382 0.76 HRH1 (0.34) CCR1HRH1LMNASLC6A2CYP1A2
SCHEMBL15478326 0.74 CCR1 (0.58) CCR1HRH1TBXA2RCHRM2
SCHEMBL18633703 0.72 CCR1 (0.32) CCR1HRH1TBXA2R
SCHEMBL18633704 0.69 CCR1 (0.34) CCR1HRH1TBXA2R
SCHEMBL13824505 0.69 CCR1 (0.32) CCR1HRH1TBXA2R
SCHEMBL18633833 0.69 CCR1 (0.42) CCR1HRH1LMNACYP3A4TP53
SCHEMBL12121948 0.67 CCR1 (0.68) CCR1HRH1TBXA2RLMNACYP3A4
SCHEMBL15478321 0.66 CCR1 (0.43) CCR1HRH1LMNACYP3A4TP53
SCHEMBL12936668 0.65 CCR1 (0.43) CCR1HRH1CYP3A4TP53CYP1A2
SCHEMBL18896008 0.63 HRH3 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback